NovaBay Pharmaceuticals Stock Quote NBY - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

2.00

Bid

Ask

Volume

0.00 Day's Range 0.00

1.85 52 Week Range 44.80

Market Cap

2.303M

Previous Close

2.00

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

8,894,653

Shares Outstanding

1,151,715

Dividend Yield

PE Ratio

-0.14

Earnings Per Share (EPS)

-14.5

Revenue

14.73M

Net Profit

-16.7M

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare and skincare products. Its leading product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is proven in laboratory testing to have broad antimicrobial... NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare and skincare products. Its leading product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is proven in laboratory testing to have broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available direct to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.novabay.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

NovaBay Pharmaceuticals Inc New is listed in the Pharmaceutical Preparations sector of the American Stock Exchange with ticker NBY. The last closing price for NovaBay Pharmaceuticals was $2. Over the last year, NovaBay Pharmaceuticals shares have traded in a share price range of $ 1.85 to $ 44.80.

NovaBay Pharmaceuticals currently has 1,151,715 shares outstanding. The market capitalization of NovaBay Pharmaceuticals is $2.30 million. NovaBay Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.14.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.33	-14.1630901288	2.33	2.33	1.85	62945	2.07812089	CS
4	-0.13	-6.10328638498	2.13	2.47	1.85	94494	2.20765989	CS
12	-1.01	-33.5548172757	3.01	9.079	1.85	8894653	4.88028961	CS
26	-3.3375	-62.5292740047	5.3375	9.079	1.85	5847993	4.89898551	CS
52	-24.6	-92.4812030075	26.6	44.8	1.85	3405270	6.57899656	CS
156	-745.25	-99.7323519572	747.25	943.25	1.85	1652610	139.07254752	CS
260	-1382.25	-99.8555174282	1384.25	2670.5	1.85	2054398	735.06092625	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
SERVServe Robotics Inc	$ 12.23 (61.99%)	8.37M
NCPLNetcapital Inc	$ 0.1385 (33.17%)	13.51M
RRRichtech Robotics Inc	$ 1.94 (31.97%)	4.63M
CISOCISO Global Inc	$ 0.7691 (29.26%)	893.72k
ULYUrgent ly Inc	$ 1.90 (27.52%)	5
XCURExicure Inc	$ 0.4018 (-24.91%)	85.16k
VVOSVivos Therapeutics Inc	$ 2.05 (-16.33%)	1
SNOASonoma Pharmaceuticals Inc	$ 0.265 (-13.96%)	540
RYAAYRyanair Holdings PLC	$ 98.70 (-13.66%)	13.07k
PRTGPortage Biotech Inc	$ 0.1982 (-13.49%)	76.94k
NCPLNetcapital Inc	$ 0.1385 (33.17%)	13.51M
SERVServe Robotics Inc	$ 12.23 (61.99%)	8.37M
RRRichtech Robotics Inc	$ 1.94 (31.97%)	4.63M
SQQQProShares UltraPro Short QQQ	$ 8.31 (-1.77%)	1.34M
MAXNMaxeon Solar Technologies Ltd	$ 0.2191 (1.62%)	1.3M